Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,085,386 | 9,532,950 | 5,210,979 | 4,760,285 | 5,835,627 |
| Depreciation Amortization | 5,053,499 | 4,166,286 | 3,652,887 | 4,748,070 | 5,020,766 |
| Income taxes - deferred | -858,587 | -1,027,443 | -599,777 | -1,391,331 | -1,688,211 |
| Accounts receivable | -41,335 | -597,929 | 185,909 | -547,427 | -30,574 |
| Accounts payable and accrued liabilities | 318,870 | 652,183 | 494,650 | 267,606 | 635,405 |
| Other Working Capital | -1,511,680 | 167,284 | 916,265 | 1,171,472 | 1,272,140 |
| Other Operating Activity | -1,495,146 | -4,552,849 | -1,187,382 | 196,541 | -822,834 |
| Operating Cash Flow | $6,551,007 | $8,340,483 | $8,673,531 | $9,205,216 | $10,222,320 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -68,498 | -184,239 | -3,320 | -97,715 | 164,833 |
| PPE Investments | 219,666 | -1,606,156 | -2,073,769 | -2,843,734 | -1,712,139 |
| Purchase Of Investment | -15,345,910 | -1,482,954 | -701,584 | -401,965 | -3,052,073 |
| Other Investing Activity | -8 | 0 | 0 | 0 | 1 |
| Investing Cash Flow | $-15,194,750 | $-3,273,349 | $-2,778,673 | $-3,343,414 | $-4,599,378 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -198,408 | 33,909 | 106,234 | -220,970 | -430,693 |
| Debt Issued | 11,428,540 | 46,342 | 5,281,802 | 2,501,731 | 3,961,314 |
| Debt Repayment | -929,447 | -2,676,550 | -2,850,602 | -786,163 | -4,030,438 |
| Common Stock Issued | 209,037 | 360,566 | 337,513 | 637,370 | 905,253 |
| Common Stock Repurchased | -1,300,281 | -2,443,708 | -3,217,993 | -1,980,954 | -2,394,069 |
| Dividend Paid | -4,472,447 | -4,210,368 | -4,182,948 | -4,115,142 | -4,899,800 |
| Other Financing Activity | -90,940 | -41,822 | -12,173 | -8,883 | 2,659 |
| Financing Cash Flow | $4,646,054 | $-8,931,631 | $-4,538,167 | $-3,973,011 | $-6,885,774 |
| Exchange Rate Effect | 1,181 | -83,642 | -111,767 | -283,152 | 45,196 |
| Beginning Cash Position | 12,182,010 | 11,611,570 | 10,123,180 | 8,151,446 | 10,976,030 |
| End Cash Position | 8,178,425 | 11,659,040 | 11,368,100 | 10,157,940 | 9,758,392 |
| Net Cash Flow | $-4,003,590 | $47,473 | $1,244,925 | $2,006,493 | $-1,217,639 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,551,007 | 8,340,483 | 8,673,531 | 9,205,216 | 10,222,320 |
| Capital Expenditure | -2,334,837 | -2,210,867 | -2,305,048 | -3,078,029 | -2,069,720 |
| Free Cash Flow | 4,216,170 | 6,129,616 | 6,368,483 | 6,127,187 | 8,152,600 |